Avastin

In the US, Avastin (bevacizumab systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic, Colorectal Cancer, Glioblastoma Multiforme, Macular Degeneration, Malignant Glioma, Neurofibromatosis, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Renal Cell Carcinoma and Solid Tumors.

US matches:

• Avastin


• Avastin Solution

UK matches:

• Avastin 25mg/ml concentrate for solution for infusion (SPC)

Ingredient matches for Avastin

Bevacizumab

Bevacizumab is reported as an ingredient of Avastin in the following countries:

• Algeria


• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Bulgaria


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Egypt


• Finland


• France


• Georgia


• Germany


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Philippines


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Yemen

Simvastatin

Simvastatin is reported as an ingredient of Avastin in the following countries:

• Bangladesh

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.